BDD 2020 Online - Posters

24 april 2020
Take a look at our BDD 2020 posters and listen to the key points recorded by the authors.
P1

Poster 1

Efficacy and Safety of Baricitinib in Moderate to Severe Atopic Dermatitis: Results of Two Phase 3 Monotherapy Randomized, Double-Blind, Placebo-Controlled 16-week Trials (BREEZE-AD1 and BREEZE-AD2.

P2

Poster 2

Rapid and Concurrent Improvements in Signs and Symptoms of Atopic Dermatitis with Baricitinib in Phase 3 Studies.

P3

Poster 3

A Belgian Consensus On The Definition Of A Treat-To-Target Outcome Set In Psoriasis Management.

P4

Poster 4

Novel mutation in the ichthyin gene erroneously diagnosed and treated as ‘Ichthyosis vulgaris’ and ‘Psoriasis’.

P5

Poster 5

The many faces of granulomatous facial eruptions: a case report of granulomatous acne rosacea.

P6

Poster 6

Secondary resistance to Vismodegib through acquired pathogenic SMO mutations: a case series.

P7

Poster 7

Skin parameter maps in multispectral dermoscopy.

View the poster more closely.

P8

Poster 8

Utility of patch testing for the diagnosis of delayed-type hypersensitivity reactions to clindamycin.

P9

Poster 9

Diagnostic approach to harlequin syndrome: a case report.

202004 19c20 poster Myth SKIN

Poster 10

Myth, belief and dogmatic thinking moves into hair science and technology during our XXIst century.

P11

Poster 11

Secukinumab sustainability: The Belgian Experience.

P12

Poster 12

Acral pigmented lesions: do dermoscopy!

View the poster more closely.

P13

Poster 13

Inspect the skin, but don’t forget the brain: a case of Giant Congenital Melanocytic Nevus in a newborn.

P14

Poster 14

Optimizing skin cancer detection in the general population: an early access lesion-directed consultation.

P15

Poster 15

Nailfold videocapillaroscopy: a diagnostic tool when clinical evaluation is misleading.

P16

Poster 16

Efficacy and Safety of Ixekizumab in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Pediatric Patients with Moderate-to-Severe Plaque Psoriasis.

P17

Poster 17

A Head-to-Head Comparison of Ixekizumab Versus Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis: 12-Week Efficacy, Safety, and Speed of Response from a Randomized, Double-Blinded Trial.

P18 202004 19d11 poster Acad SKIN

Poster 18

A unique collection of books focussing on hair and skin at the "Fonds Van Neste".

Verder lezen?

Word nu lid van de Koninklijke Belgische Vereniging voor Dermatologie en Venerologie (KBVDV) en de Beroepsvereniging der Belgische Dermatologen en Venerologen (BBDV)!

Als lid van deze verenigingen geniet je tal van voordelen, waaronder toegang tot alle content van onze website en
de website van de Beroepsvereniging. Daarnaast betaal je een sterk verlaagd voordeeltarief voor de jaarlijkse Belgian Dermatology days én ontvang je regelmatig newsletters met relevante informatie over de uitoefening van ons beroep. Bovendien krijg je ook een korting op de website van contactallergie (met oa. allergenenlijsten) en een polis burgerlijke aansprakelijkheid beroep, speciaal ontwikkeld voor onze discipline, aan zeer gunstige voorwaarden.